3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Prostatic Neoplasms
3
Pancreatic Neoplasms
2
Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Hematologic Neoplasms
2
Advanced Malignant Solid Neoplasm
2
Urinary Bladder Neoplasms
1
Spondylitis, Ankylosing
1
Skin Carcinoma
1
Signs and Symptoms
1
Rectal Neoplasms
1
Psoriasis
1
Overweight
1
Ovarian Neoplasms
1
Obesity
1
Neoplasm Metastasis
1
Motor Activity
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Lymphedema
1
Lupus Erythematosus, Systemic
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Inflammatory Bowel Diseases
1
Hematopoietic and Lymphatic System Neoplasm
1
Endometrial Neoplasms
1
Crohn Disease
1
Colorectal Neoplasms
1
Interventions
Cyclophosphamide
9
Nivolumab
8
pembrolizumab
7
fludarabine phosphate
7
fludarabine
6
Mycophenolic Acid
6
Magnetic Resonance Spectroscopy
6
Whole-Body Irradiation
5
Vinblastine
5
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
Doxorubicin
5
Dacarbazine
5
Cyclosporine
5
Brentuximab Vedotin
5
Melphalan
4
Busulfan
4
pegfilgrastim
3
Tacrolimus
3
Specimen Handling
3
Etoposide
3
Thiotepa
2
Sirolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Fluorodeoxyglucose F18
2
Cyclosporins
2
Clofarabine
2
Azacitidine
2
treosulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
Methods
×
30 days
×
Clear all
No trials found.